MSL
AMPH icon

Mackay Shields LLC’s Amphastar Pharmaceuticals AMPH Stock Holding History

Mackay Shields LLC’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-101,200
Closed -$1.85M – 735
2021
Q1 		$1.85M Sell
101,200
-14,400
-12% -$268K 0.01% 807
2020
Q4 		$2.32M Sell
115,600
-1,200
-1% -$23.4K 0.02% 797
2020
Q3 		$2.19M Buy
116,800
+86,900
+291% +$1.75M 0.01% 751
2020
Q2 		$672K Buy
+29,900
New +$548K 0.01% 1130
2020
Q1 		– Sell
-179,478
Closed -$3.46M – 1389
2019
Q4 		$3.46M Buy
179,478
+14,100
+9% +$270K 0.02% 638
2019
Q3 		$3.28M Sell
165,378
-16,000
-9% -$333K 0.02% 697
2019
Q2 		$3.83M Buy
181,378
+116,536
+180% +$2.44M 0.03% 648
2019
Q1 		$1.32M Sell
64,842
-18,200
-22% -$408K 0.01% 900
2018
Q4 		$1.65M Sell
83,042
-122,058
-60% -$2.41M 0.01% 732
2018
Q3 		$3.95M Sell
205,100
-29,400
-13% -$524K 0.03% 503
2018
Q2 		$3.58M Buy
234,500
+5,500
+2% +$96.1K 0.02% 592
2018
Q1 		$4.29M Buy
+229,000
New +$4.3M 0.03% 534

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mackay Shields LLC's AMPH Position: Q2 2021 in Review

Mackay Shields LLC sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2021, closing a stake of 101,200 shares — an estimated $1.85M sold.

Mackay Shields LLC first reported a position in AMPH in Q1 2018 and held it in 12 quarters. The position peaked at $4.29M in Q1 2018. 146 funds tracked by Wall St. Rank hold AMPH as of Q2 2021.

  • Mackay Shields LLC reported no remaining Amphastar Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 101,200 Amphastar Pharmaceuticals shares in Q2 2021, an estimated $1.85M.
  • Mackay Shields LLC first reported a position in Amphastar Pharmaceuticals in Q1 2018 and held it in 12 quarters.
  • Mackay Shields LLC's Amphastar Pharmaceuticals position peaked at $4.29M in Q1 2018.
  • 146 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.